Based upon the results of this exploratory pilot study, we suggest that DOC should be considered as a new seemingly reliable complementary biomarker for monitoring of disease in chronic hepatitis B patients that can be used together with ALT for improved diagnostic power. This evidence concerns the gene GPT and chronic hepatitis B virus infection.